**7. Prospectives**

Regenerative medicine is an evolving field of research and therapeutics in which adipose tissue and ADSCs hold great promise for translational research and future clinical applications in many fields of tissue regeneration with a wide range of potential clinical implications. In the past decade, preclinical data from in vitro studies and pre-clinical animal models has been provided on the reproducibility, safety and efficacy of ADSCs in tissue regeneration or tissue engineering, supporting their use in clinical applications and establishing the basis for a translational application in the bedside: consistently, recent preliminary clinical trials have confirmed positive outcomes. The enhancing effect of ADSCs on autologous repair might enable better clinical outcomes and play a relevant role in healing acute and chronic tissue damage. Thus, more accurate information regarding optimal management and methods to promote differentiation lineages (among which differentiation factors, cell scaffolds, cell culture conditions) are strongly required. Further translational research, adequate clinical investigation and novel strategies should be promoted and designed to overcome current limitations, encourage future therapeutic implementation and face challenges posed by regenerative medicine.
